<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01173991</url>
  </required_header>
  <id_info>
    <org_study_id>GIOCAR</org_study_id>
    <nct_id>NCT01173991</nct_id>
  </id_info>
  <brief_title>Carbohydrate Counting in Adults With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion</brief_title>
  <acronym>GIOCAR</acronym>
  <official_title>Clinical Assessment of Carbohydrate Counting in Adult Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion: a Randomized Controlled Study (GIOCAR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators postulate that carbohydrate (CHO) counting in adult patients with type 1
      diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII) may
      improve glycemic control, glycemic variability and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was designed as a randomized, controlled (versus standard education), open,
      one-center trial. Patients in group 1 were taught carbohydrate counting to estimate insulin
      preprandial bolus, while the patients in group 2 followed standard education. Primary outcome
      (glycosylated hemoglobin, HbA1c) and secondary outcomes (fasting glucose, glycemic
      variability, insulin requirement, body mass index (BMI), waist circumference, quality of
      life) were measured at baseline, 3, and 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated haemoglobin (HbA1c)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting glucose</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic variability (mean, sd, min, max, variability range, BG in target range, LBGI, HBGI) based on capillary glucose data</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily insulin requirement (basal daily requirement, bolus daily requirement, total daily requirement)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life by Diabetes Specific Quality of Life Scale (DSQOLS) questionnaire</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia (capillary glucose&lt;50 mg/dl)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Insulin Pump, Programmable</condition>
  <arm_group>
    <arm_group_label>Carbohydrate counting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group received carbohydrate counting training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group received standard education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Carbohydrate counting training</intervention_name>
    <description>Carbohydrate counting was taught during 4-5 individual sessions with a dietician and a diabetologist.</description>
    <arm_group_label>Carbohydrate counting</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 1 diabetes mellitus

          -  age 18-65

          -  continuous subcutaneous insulin infusion for at least 3 months

        Exclusion Criteria:

          -  patients who have already been trained in carbohydrate counting

          -  known hypothyroidism not on replacement therapy

          -  renal disease (serum creatinine &gt;1.4 mg/dl in females and &gt;1.7 mg/dl in males)

          -  patients with celiac disease

          -  pregnancy

          -  serious diseases or disabilities which may interfere with study assessments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emanuele Bosi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Raffaele Scientific Institute, Milano Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Raffaele Scientific Institute</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>August 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2010</study_first_posted>
  <last_update_submitted>August 2, 2010</last_update_submitted>
  <last_update_submitted_qc>August 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2010</last_update_posted>
  <responsible_party>
    <name_title>Emanuele Bosi</name_title>
    <organization>IRCCS San Raffaele</organization>
  </responsible_party>
  <keyword>carbohydrate counting</keyword>
  <keyword>continuous subcutaneous insulin infusion</keyword>
  <keyword>type 1 diabetes mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

